Code No. |
CY-1151V2 |
プリント |
CycLex® SIRT1/Sir2 Deacetylase Fluorometric Assay Kit Ver.2
|
価格(税別) |
¥64,000
|
包装 |
100 assays |
在庫 |
10以上
(2024/03/29 00:05時点)
|
キット構成品 |
SIRT1 Assay Buffer, Fluoro-Substrate Peptide (0.2 mM), Fluoro-Deacetylated Peptide (0.2 mM), NAD (2 mM), Developer, Recombinant SIRT1, Stop Solution |
使用目的 |
This kit is designed for the rapid and sensitive evaluation of SIRT1/Sir2 inhibitors or activators using crude SIRT1/Sir2 fraction or purified SIRT1/Sir2. |
保存温度 |
-80°C |
メーカー |
MBL |
関連製品 |
CY-1140 CycLex® Cellular Histone Acetylation Assay Kit CY-1150V2 CycLex® HDACs Deacetylase Fluorometric Assay Kit Ver.2 CY-1152V2 CycLex® SIRT2 Deacetylase Fluorometric Assay Kit Ver.2 CY-1153V2 CycLex® SIRT3 Deacetylase Fluorometric Assay Kit Ver.2 CY-1156V2 CycLex® SIRT6 Deacetylase Fluorometric Assay Kit Ver.2 CY-1158V2 CycLex® HDAC8 Deacetylase Fluorometric Assay Kit Ver.2 CY-E1251 NAMPT (Human, Active) CY-1251V2 CycLex® NAMPT Colorimetric Assay Kit Ver.2 CY-1252V2 CycLex® NMNAT1 Colorimetric Assay Kit Ver.2 CY-1253V2 CycLex® NAD+/NADH Colorimetric Assay Kit Ver.2
|
製品カテゴリー |
分野:がん ドラッグディスカバリー |
データ |
|
使用文献 |
- Kayashima Y et al. Alkylresorcinols activate SIRT1 and delay ageing in Drosophila melanogaster. Sci Rep. 7, 43679 (2017)(PMID:28252007)
- Peng J et al. Quercetin Improves Glucose and Lipid Metabolism of Diabetic Rats: Involvement of Akt Signaling and SIRT1. J Diabetes Res. 2017, 3417306 (2017)(PMID:29379801)
- Conti V et al. SIRT1 Activity in Peripheral Blood Mononuclear Cells Correlates with Altered Lung Function in Patients with Chronic Obstructive Pulmonary Disease. Oxid Med Cell Longev. 2018, 9391261 (2018)(PMID:29861836)
- Shigemoto R et al. 5-Methylmellein is a novel inhibitor of fungal sirtuin and modulates fungal secondary metabolite production. J Gen Appl Microbiol. (2018) In press.(PMID:29794367)
- Corbi G et al. Phenolic Plant Extracts Induce Sirt1 Activity and Increase Antioxidant Levels in the Rabbit's Heart and Liver. Oxid Med Cell Longev. 2018, 2731289 (2018)(PMID:30116475)
- Corbi G et al. Cardiac Rehabilitation Increases SIRT1 Activity and β-Hydroxybutyrate Levels and Decreases Oxidative Stress in Patients with HF with Preserved Ejection Fraction. Oxid Med Cell Longev. 2019, 7049237 (2019)
(PMID:31885811)
- Chiang S et al. The potential of the novel NAD+ supplementing agent, SNH6, as a therapeutic strategy for the treatment of Friedreich's ataxia. Pharmacol Res.155, 104680 (2020)(PMID:32032665)
ELISA - Xu S et al. Evidence for SIRT1 Mediated HMGB1 Release From Kidney Cells in the Early Stages of Hemorrhagic Shock. Front Physiol. 854, 10. 854 (2019)(PMID:31333497)
Other - Yaku K et al. Metabolism and biochemical properties of nicotinamide adenine dinucleotide (NAD) analogs, nicotinamide guanine dinucleotide (NGD) and nicotinamide hypoxanthine dinucleotide (NHD).Sci Rep. 9, 13102 (2019)(PMID:31511627)
|